Merck
MRK
#55
Rank
โ‚น25.240 T
Marketcap
โ‚น10,105
Share price
1.78%
Change (1 day)
20.36%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): โ‚น657.78

According to Merck's latest financial reports the company's current EPS (TTM) is โ‚น695.90. In 2024 the company made an earnings per share (EPS) of โ‚น619.42 an increase over its 2023 EPS that were of โ‚น14.05.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น657.786.19%
2024โ‚น619.424308.46%
2023โ‚น14.05-97.32%
2022โ‚น525.1010.92%
2021โ‚น473.4184.68%
2020โ‚น256.34-27.2%
2019โ‚น352.1163.44%
2018โ‚น215.43151.11%
2017โ‚น85.79-54.58%
2016โ‚น188.8730.21%
2015โ‚น145.05-61.99%
2014โ‚น381.57180.51%
2013โ‚น136.02-31.82%
2012โ‚น199.506.62%
2011โ‚น187.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น956.68 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น674.48-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น157.62-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น738.36 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น1,880 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,194 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น339.59-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น272.17-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น329.53-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น57.73-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel